Lv2
170 积分 2023-07-20 加入
How I treat anemia in myelofibrosis
2天前
已完结
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
23天前
已完结
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
23天前
已完结
Optimal GVHD Prophylaxis
1个月前
已完结
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis
1个月前
已完结
Cytokine Storm Syndromes Associated with Epstein–Barr Virus
1个月前
已完结
Sorafenib as a Salvage Therapy in FLT3-ITD Negative Relapse/ Refractory Acute Myeloid Leukemia
2个月前
已完结
Light and shade of ruxolitinib: positive role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in patients with myelofibrosis
2个月前
已完结
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
4个月前
已关闭
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT
4个月前
已完结
皖公网安备34019202002308
